Biotech article - March 19, 2025
Scaling the next generation of T-cell therapy
Understanding the science is one thing, but being able to manufacture T-cell therapies at scale is a different matter. TCR-T cell therapies offer a path forward at a fraction of the cost and time of manufacturing a living cell as a product.
Pharma article - February 25, 2025
NMD Pharma announces FDA Orphan Drug designation
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for NMD670, a novel, oral, small molecule inhibitor of the skeletal muscle-specific chloride ion channel ClC-1, for the treatment of Charcot-Marie-Tooth disease (CMT).
Pharma article - November 12, 2024
Opinion & Debate: The Swedish life science strategy needs to be more specific
In a press release from Lif (the trade association for the research-based pharmaceutical industry in Sweden) they state that the strategy needs to be supplemented with the necessary connection to the fact that new medicines and innovations need to be used early on in healthcare.
In a new job - August 13, 2024
She is the new SVP of Clinical Operations & Pharmacovigilance at Calluna
Margrethe Sørgaard joins the company’s cross-functional R&D team following Calluna’s launch, to oversee the strategic development of the company’s clinical programs in line with regulatory guidelines and safety requirements. With over 25 years’ experience from different leading positions in clinical development and operation, medical affairs, and drug safety/pharmacovigilance, she will play a pivotal role in […]
Pharma article - July 1, 2024
The Swedish government’s announcement to strengthen clinical trials is welcomed
The decision, which is based on the proposals put forward by the investigator Peter Asplund and which means that a national partnership is established, is welcomed by both Lif and SwedenBIO. The government’s announcement on 27 June means that the Swedish Medical Products Agency will be tasked with proposing measures to improve conditions and strengthen […]
Pharma article - April 24, 2024
Novel AI model detects 90% of lymphatic cancer cases
Researchers at Chalmers University of Technology in Sweden have carried out one of the largest studies to date using AI (artificial intelligence)-assisted image analysis of lymphoma. “An AI-based computer system for interpreting medical images also contributes to increased equality in healthcare by giving patients access to the same expertise and being able to have their […]
